INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Rescuing A Global Program For NDA Success
Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
Taming The Complex Clinical-Trial Ecosystem
To navigate the growing number of vendor portals required for clinical trials, sites are seeking a vendor- and sponsor-agnostic solution to enable single sign-on and study organization.
-
Flexible Packaging, Labeling And Distribution For Diverse Drug Types
Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.
-
Building Bioanalysis Infrastructure For Modern Drug Development
Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.
-
How Remote Monitoring Is Transforming Compliance5/8/2026
Discover how remote monitoring is transforming pharmacy compliance. Shift from manual, onsite burdens to digital workflows that ensure real-time accuracy and continuous audit readiness.
-
PCI Capacity Update July 2025: Small Molecule Drug Product/Finished Dosage Form7/29/2025
Dr. Rebecca Coutts highlights PCI’s high potent oral solid dose (OSD) and oral liquid capabilities, focusing on site expertise, specialized infrastructure, and handling of complex molecules.
-
How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs3/17/2025
Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.
-
Global e-Consent Matrix3/9/2026
Navigate complex regional regulations and identity requirements to modernize your global clinical trial enrollment. Ensure compliance and access while moving toward digital participant engagement.
-
8 Critical Questions To Ask Your IRB2/5/2025
This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.
-
Our regulatory consultants take action and move your research forward. If you’re looking for help in the development of innovative life science and digital health products, then Advarra® is the answer.
-
Remove the administrative burden of clinical trials for patients while ensuring compliance and offering global accessibility.
-
Niche CRO with a difference
Worldwide Clinical Trials Oncology is a niche oncology CRO devoting time, energy, and capital to supporting biotechs in bringing next-generation therapies to patients in need. Oncology clinical research is complex, demanding, and continually evolving. Bringing effective therapies to proof-of-concept and then to market as fast as possible is our passion because every second counts for patients with cancer and their families.
-
The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.
Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.